|
Volumn 54, Issue 10, 2001, Pages 848-849
|
14-(2′,3′,5′-trihydroxyphenyl)tetradecan-2-ol, a novel acetylcholinesterase inhibitor from Chrysosporium sp. [1]
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
14 (2',3',5' TRIHYDROXYPHENYL)TETRADECAN 2 OL;
CHOLINESTERASE INHIBITOR;
NEOSTIGMINE;
TACRINE;
UNCLASSIFIED DRUG;
14-(2',3',5'-TRIHYDROXYPHENYL)TETRADECAN-2-OL;
FATTY ALCOHOL;
CHRYSOSPORIUM;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG ISOLATION;
DRUG MANUFACTURE;
DRUG MECHANISM;
DRUG SCREENING;
DRUG STRUCTURE;
FUNGUS CULTURE;
LETTER;
MEDICAL LITERATURE;
MICROORGANISM;
PHYSICAL CHEMISTRY;
PRIORITY JOURNAL;
ANIMAL;
CHEMISTRY;
CULTURE MEDIUM;
ELECTROPHORUS;
FERMENTATION;
HUMAN;
ISOLATION AND PURIFICATION;
METABOLISM;
RAT;
ULTRAVIOLET SPECTROPHOTOMETRY;
CHRYSOSPORIUM;
ANIMALS;
CHEMISTRY, PHYSICAL;
CHOLINESTERASE INHIBITORS;
CHRYSOSPORIUM;
CULTURE MEDIA;
ELECTROPHORUS;
FATTY ALCOHOLS;
FERMENTATION;
HUMANS;
NEOSTIGMINE;
RATS;
SPECTROPHOTOMETRY, ULTRAVIOLET;
|
EID: 0035166794
PISSN: 00218820
EISSN: None
Source Type: Journal
DOI: 10.7164/antibiotics.54.848 Document Type: Letter |
Times cited : (17)
|
References (4)
|